Lucero-Prisno Don Eliseo, Elhadi Yasir Ahmed Mohammed, Modber Mohamed AbdulKareem Adam, Musa Mohamed Babiker, Mohammed Salma Elmukashfi Eltahir, Hassan Khlood Fathi, Dafallah Alaa, Lin Xu, Ahmadi Attaullah, Adeyemi Sylvester, Ekpenyong Aniekan, Adebisi Yusuff Adebayo
Department of Global Health and Development, London School of Hygiene and Tropical Medicine, London, United Kingdom.
High Institute of Public Health, Department of Health Administration and Behavioral Sciences, Alexandria University, Alexandria, Egypt.
Public Health Pract (Oxf). 2020 Nov 23;1:100060. doi: 10.1016/j.puhip.2020.100060. eCollection 2020 Nov.
Sudan is witnessing severe drugs, medicines, and medical supplies shortages, which present a major impediment to the provision of emergency healthcare services. Drug insecurity in Sudan is as a result of several accumulated factors, primarily due to worsening economic condition, inappropriate pricing policy, privatization of the pharmaceutical sector, poor manufacturing and weak weak weregulatory system. These could threaten patient health through replacement of highly efficacious medicines with less effective alternatives and by impacting the scheduling of urgent medical operations and procedures. Drug and medicine shortages are of catastrophic impact especially amid the current epidemic of COVID-19 where these are salient needs. Efforts should be quickly directed to ensure immediate access to pharmaceutical products and other essential health commodities. Effective policies on drug importation, production, pricing, and distribution should be established to avoid the consequences of an impending crisis.
苏丹正面临严重的药品和医疗用品短缺问题，这对提供紧急医疗服务构成了重大障碍。苏丹的药品供应不安全是多种因素累积的结果，主要原因是经济状况恶化、定价政策不当、制药行业私有化、制造业薄弱以及监管体系不力。这些因素可能通过用效果较差的替代品取代高效药品，以及影响紧急医疗手术和程序的安排，威胁患者健康。药品短缺具有灾难性影响，尤其是在当前新冠疫情期间，这些物资的需求极为突出。应迅速采取措施，确保立即获得药品和其他基本医疗用品。应制定有效的药品进口、生产、定价和分销政策，以避免即将到来的危机造成的后果。
